Place de la chimiothérapie de type témozolomide pour les astrocytomes intramédullaires de grade II de l'adulte : notre expérience

[1]  J. Chi,et al.  Infiltrating spinal cord astrocytomas: Epidemiology, diagnosis, treatments and future directions , 2016, Journal of Clinical Neuroscience.

[2]  M. Cykowski,et al.  Spinal Anaplastic Oligodendroglioma With Oligodendrogliomatosis: Molecular Markers and Management: Case Report. , 2016, Neurosurgery.

[3]  R. Komotar,et al.  Primary spinal cord glioblastoma multiforme treated with temozolomide , 2015, Journal of Clinical Neuroscience.

[4]  M. Bynevelt,et al.  Marked functional improvement after combined chemoradiotherapy for cervical spine glioblastoma causing quadriparesis in an adolescent , 2014, BMJ Case Reports.

[5]  Y. Ha,et al.  Effect of Combined Bevacizumab and Temozolomide Treatment on Intramedullary Spinal Cord Tumor , 2014, Spine.

[6]  P. Brown,et al.  Treatment, prognostic factors, and outcomes in spinal cord astrocytomas. , 2013, Neuro-oncology.

[7]  T. Kaley,et al.  Temozolomide or bevacizumab for spinal cord high-grade gliomas , 2012, Journal of Neuro-Oncology.

[8]  X. Lou,et al.  Spinal cord anaplastic oligodendroglioma with 1p deletion: report of a relapsing case treated with temozolomide , 2011, Journal of Neuro-Oncology.

[9]  M. Chamberlain,et al.  Adult Primary Intradural Spinal Cord Tumors: A Review , 2011, Current neurology and neuroscience reports.

[10]  A. Friedman,et al.  Impact of Tumor Histology on Resectability and Neurological Outcome in Primary Intramedullary Spinal Cord Tumors: A Single-Center Experience With 102 Patients , 2011, Neurosurgery.

[11]  H. Lien,et al.  Prolonged survival of a patient with cervical intramedullary glioblastoma multiforme treated with total resection, radiation therapy, and temozolomide. , 2010, Anti-cancer drugs.

[12]  Mahlon D. Johnson,et al.  Primary spinal cord glioma: a Surveillance, Epidemiology, and End Results database study , 2010, Journal of Neuro-Oncology.

[13]  T. Witham,et al.  Factors associated with progression-free survival and long-term neurological outcome after resection of intramedullary spinal cord tumors: analysis of 101 consecutive cases. , 2009, Journal of neurosurgery. Spine.

[14]  M. Bilsky,et al.  Primary Intramedullary Tumors of the Spinal Cord , 2009, Spine.

[15]  C. Hawkins,et al.  Survival and functional outcome of childhood spinal cord low-grade gliomas. Clinical article. , 2009, Journal of neurosurgery. Pediatrics.

[16]  P. Barša,et al.  Prognostic factors in intramedullary astrocytomas: a literature review , 2009, European Spine Journal.

[17]  B. Vaillant,et al.  Treatment of spinal cord tumors , 2009, Current treatment options in neurology.

[18]  M. Chamberlain.  Temozolomide for recurrent low‐grade spinal cord gliomas in adults , 2008, Cancer.

[19]  A. Markoe,et al.  Spinal cord gliomas: A multi-institutional retrospective analysis. , 2006, International journal of radiation oncology, biology, physics.

[20]  A. Alaraj,et al.  Role of temozolomide in spinal cord low grade astrocytomas: results in two paediatric patients , 2006, Acta Neurochirurgica.

[21]  D. Ashley,et al.  Carboplatin chemotherapy for progressive intramedullary spinal cord low-grade gliomas in children: three case studies and a review of the literature. , 2001, Neuro-oncology.

[22]  J. Waldron,et al.  A retrospective analysis of 52 cases of spinal cord glioma managed with radiation therapy. , 2000, International journal of radiation oncology, biology, physics.

[23]  C. Balmaceda.  Chemotherapy for Intramedullary Spinal Cord Tumors , 2000, Journal of Neuro-Oncology.

[24]  B. Minassian,et al.  Loss of ability to sneeze in lateral medullary syndrome , 2000, Neurology.

[25]  J. Grill,et al.  Chemotherapy for unresectable and recurrent intramedullary glial tumours in children , 1999 .

[26]  H. Coakham,et al.  Chemotherapy for spinal cord astrocytoma: can natural history be modified? , 1998, Child’s Nervous System.

[27]  E. Bouffet,et al.  Chemotherapy for spinal cord astrocytoma. , 1997, Medical and pediatric oncology.

[28]  J. Farmer,et al.  Adult intramedullary astrocytomas of the spinal cord. , 1992, Journal of neurosurgery.

[29]  Chae-Yong Kim,et al.  Temozolomide for malignant primary spinal cord glioma: an experience of six cases and a literature review , 2010, Journal of Neuro-Oncology.

[30]  J. Mora,et al.  Successful treatment of childhood intramedullary spinal cord astrocytomas with irinotecan and cisplatin. , 2007, Neuro-oncology.

[31]  J. Brotchi,et al.  Current Management of Spinal Cord Tumors , 1999 .